Patient assistance program definition

Patient assistance program means a program that a manufacturer offers to the public in which a consumer may reduce the consumer's out-of-pocket costs for prescription drugs by using coupons, discount cards, prepaid gift cards, manufacturer debit cards, or by other means.
Patient assistance program means programs created by drug companies, such as Sanofi, to offer free or low cost drugs to individuals who are unable to pay for their medication. These Programs may also be called indigent drug programs, charitable drug programs or medication assistance programs.
Patient assistance program means a program that a manufacturer offers to the general public in which a consumer may reduce the consumer’s out-of-pocket costs for prescription drugs by using coupons or discount cards, receiving copayment assistance or by other means.

Examples of Patient assistance program in a sentence

  • Patient assistance program information may also be provided for non-formulary prior authorization approvals.


More Definitions of Patient assistance program

Patient assistance program or “PAP” shall mean the Jazz Pharmaceuticals' sponsored program that provides Product at no cost to eligible patients. Jazz Pharmaceuticals has sole discretion over the eligibility criteria and operation of the PAP. “PAP Patient” shall mean a Patient who has been approved as eligible to participate in the PAP.
Patient assistance program means a program in which pharmaceuti- cal manufacturers provide financial or medication assistance to low-income or medically indigent individuals.
Patient assistance program is defined in Section 4.2(b)(xxi) of the Agreement.
Patient assistance program means a program that a manufacturer offers to the general public
Patient assistance program shall have the meaning set forth in Section 3.8(g)(i)
Patient assistance program has the meaning set forth in the definition ofNet Sales’.
Patient assistance program means a qualified program offered by a pharmaceutical manufacturer under which the manufacturer provides drugs to financially disadvantaged persons at no charge or at a substantially reduced cost. The term does not include the provision of a drug as part of a clinical trial.